
Beijing confirmed the nomination of National Health Commission official Dr Song Li for WHO Director-General on Thursday (8 October). The move expands the candidate field to seven amidst severe geopolitical ruptures shaking up the agency, with experts warning this move could further heighten superpower tensions.
In announcing the bid, Chinese officials framed the candidacy around global solidarity and strengthening multilateralism.
“China’s decision to nominate Dr Song Li reflects China’s aspiration to work for a global community of health for all and demonstrates China’s firm support for multilateralism,” Foreign Ministry spokesperson Mao Ning told reporters during a press briefing in response to a question by Reuters.

“If elected, it will help the WHO play a more positive role in promoting the health and wellbeing of all humanity,” she added.
Until late last month, Song served as Director-General of the Department of Women and Child Health in China’s National Health Commission. She is a physician-scientist trained at Peking University and Harvard, bringing over two decades of experience in maternal policy, epidemic response, and WHO technical advisory groups.
Observers note Song’s technical focus contrasts with established ministerial and diplomatic figures in the race.
Song bid spotlights China’s financial weight

Song’s nomination by the People’s Republic of China comes as WHO manages massive budget cuts following the declared withdrawal of the United States in January 2025. Owing $280.9 million in unpaid arrears, WHA member states did not formally recognize the move at the May 2026 World Health Assembly. But due to the unpaid dues, the US still faces the suspension of its voting rights at the 2027 World Health Assembly when the next WHO Director-General will be elected.
Global health policy experts observe that Beijing aims to fill the leadership void left by Washington’s withdrawal. According to official numbers on the WHO website, China’s total projected financial contribution to the WHO for the 2026-2027 biennium stands at $320 million through August, making it the largest state contributor in terms of assessed funding after the US withdrawal.
Among state donors, China’s funding is exceptionally concentrated in mandatory assessed dues, contrasting with traditional high-income donors from Europe, the Americas and western Asia, which distribute significant portions of their funding across core voluntary, thematic, and specified voluntary channels.
When compared against other major contributors, China ranks as the fourth-largest overall donor to the WHO, trailing only the Bill and Melinda Gates Foundation, the European Commission, and the World Bank, while sitting ahead of the United Kingdom, the GAVI Alliance, and Germany. While European Union Member States hold 27 votes in the WHA, the EU is not likely to vote en bloc, and two European nominees in the race could split their support.
Health Policy Watch reached out to the WHO asking to confirm the nomination and whether China had paid its dues for 2026 in full, but did not receive a response ahead of publication.
High geopolitical stakes for WHO

One leading US global health expert voiced serious doubts that a Chinese candidacy will indeed shake up the final race because of the high geopolitical stakes for the WHO.
“In the aftermath of COVID-19, I do not think there is a global appetite for a Chinese candidate for WHO Director-General,” Lawrence Gostin, professor of global health law at Georgetown University, told Health Policy Watch.
“A Chinese candidate would heighten geopolitical tensions, putting the WHO in a difficult and vulnerable position,” Gostin added. “It would also make rejoining the WHO far more difficult for the US, even under a Democratic administration.”
The friction stems from increased geopolitical competition between the two superpowers and a lingering political fallout over COVID-19 transparency and initial outbreak reporting. Gostin noted that bipartisan opposition in Washington and a lack of civil society support create formidable hurdles for Song across both North America and Europe.
European reactions, however, remain more divided. While one senior European official warned that a successful Chinese bid would test the WHO’s fundamental legitimacy and independence, others were less alarmist, noting that Beijing’s diplomacy remains “very nuanced” and that China is viewed in Europe as a partner as well as a competitor.
Besides geopolitical scrutiny, China’s candidacy also faces structural UN hurdles regarding geographic distribution. With Dr Margaret Chan, a dual Canadian and Chinese national from Hong Kong, having served two terms as WHO Director-General from 2007 to 2017 and the Chinese national Qu Dongyu currently heading the Food and Agriculture Organization, member states may resist concentrating more UN agency leadership into the hands of one country.
BREAKING: China Has Nominated Candidate for WHO Director General Whose Name Remains Undisclosed
Note: This piece has been updated regarding Song’s position, Dr Margaret Chan’s term dates, and WHO budget cycle data.
Image Credits: Ministry of Foreign Affairs People’s Republic of China, WHO, WHO/HPW, Georgetown Law.








































